Total Payments
$8,755
2024 Payments
$1,178
Companies
31
Transactions
342
Payment Breakdown by Category
Food & Beverage$8,712 (99.5%)
Gifts$32.34 (0.4%)
Education$11.12 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,712 | 337 | 99.5% |
| Gift | $32.34 | 1 | 0.4% |
| Education | $11.12 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,526 | 40 | $0 (2024) |
| Validus Pharmaceuticals LLC | $1,350 | 18 | $0 (2024) |
| Lundbeck LLC | $823.65 | 43 | $0 (2024) |
| Shire North American Group Inc | $533.83 | 29 | $0 (2019) |
| ABBVIE INC. | $483.37 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $440.00 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $419.88 | 19 | $0 (2024) |
| Tris Pharma Inc | $416.69 | 16 | $0 (2024) |
| ITI, Inc. | $383.15 | 13 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $346.23 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,178 | 43 | ABBVIE INC. ($215.33) |
| 2023 | $1,217 | 44 | Corium, LLC ($244.83) |
| 2022 | $893.83 | 36 | Validus Pharmaceuticals LLC ($146.21) |
| 2021 | $1,364 | 39 | Validus Pharmaceuticals LLC ($647.00) |
| 2020 | $527.85 | 21 | Otsuka America Pharmaceutical, Inc. ($136.26) |
| 2019 | $1,199 | 67 | Shire North American Group Inc ($180.77) |
| 2018 | $1,042 | 44 | Otsuka America Pharmaceutical, Inc. ($291.08) |
| 2017 | $1,335 | 48 | Otsuka America Pharmaceutical, Inc. ($766.00) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.44 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Noven Therapeutics, LLC | Secuado (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: CNS Psychiatry | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.11 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Noven Therapeutics, LLC | Secuado (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CNS Psychiatry | ||||||
| 10/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $24.85 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Central Nervous System | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Neuroscience | ||||||
| 09/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: NEUROSCIENCE | ||||||
| 08/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: Neuroscience | ||||||
| 08/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: ADHD | ||||||
| 07/24/2024 | Noven Therapeutics, LLC | Secuado (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: CNS Psychiatry | ||||||
| 07/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Moses Ramos, M.D
Dr. Moses Ramos, M.D is a Psychiatry healthcare provider based in Desoto, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013137561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Moses Ramos, M.D has received a total of $8,755 in payments from pharmaceutical and medical device companies, with $1,178 received in 2024. These payments were reported across 342 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($8,712).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Desoto, TX
- Active Since 04/26/2007
- Last Updated 10/13/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013137561
Products in Payments
- REXULTI (Drug) $1,468
- Equetro (Drug) $1,350
- VRAYLAR (Drug) $670.98
- TRINTELLIX (Drug) $569.52
- CAPLYTA (Drug) $526.31
- ABILIFY MAINTENA (Drug) $488.12
- SPRAVATO (Drug) $400.08
- Dyanavel XR (Drug) $364.68
- VYVANSE (Drug) $352.41
- QELBREE (Drug) $280.77
- Azstarys (Drug) $244.83
- INGREZZA (Drug) $198.20
- MYDAYIS (Drug) $179.56
- Secuado (Drug) $170.78
- ARISTADA (Drug) $138.61
- BRINTELLIX (Drug) $119.91
- ABILIFY ASIMTUFII (Drug) $117.44
- QUVIVIQ (Drug) $97.82
- Evekeo (Drug) $87.19
- AZSTARYS (Drug) $74.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.